SALL4 immunoreactivity predicts prognosis in Western hepatocellular carcinoma patients but is a rare event: a study of 236 cases.
about
Comparison of hepatocellular carcinoma in Eastern versus Western populations.Oncofetal gene SALL4 and prognosis in cancer: A systematic review with meta-analysis.Undifferentiated carcinoma of the esophagus: a clinicopathological study of 16 cases.Clinicopathologic characteristics of SALL4-immunopositive hepatocellular carcinoma.SALL4 Expression in Hepatocellular Carcinomas Is Associated with EpCAM-Positivity and a Poor Prognosis.SALL4 is a novel therapeutic target in intrahepatic cholangiocarcinoma.Positive immunostaining of Sal-like protein 4 is associated with poor patient survival outcome in the large and undifferentiated Korean hepatocellular carcinoma.Oncogenic protein SALL4 and ZNF217 as prognostic indicators in solid cancers: a meta‑analysis of individual studiesCancer stem cells in hepatocellular carcinoma: Therapeutic implications based on stem cell biology.Functional and clinical significance of SALL4 in breast cancer.Hepatocellular Malignant Neoplasm-NOS: A Clinicopathologic Study of 11 Cases from a Single Institution.The diagnostic and prognostic value of SALL4 in hepatoblastoma.Yolk sac tumours of the female genital tract in older adults derive commonly from somatic epithelial neoplasms: somatically derived yolk sac tumours.Higher expression of SALL4 predicts poor cancer prognosis: A meta-analysis.Spalt-like transcription factor 4 immunopositivity is associated with epithelial cell adhesion molecule expression in combined hepatocellular carcinoma and cholangiocarcinoma.
P2860
Q30245396-6165FBD7-37DD-49C6-BA11-41EF9C29EE06Q33618541-017EB88E-E465-451C-9536-DBBFA6BFD1EDQ35256138-9689AE6E-B6B3-4501-8CD6-BCEAFEAAA4D8Q35661679-46288583-4A8E-49D3-9CBD-51F3A3AD87E6Q36084140-78AB92AD-4C56-475E-A82F-91B1D811AF68Q36413790-5AEEA575-EFF0-46DF-9E8A-C3E9D154D1EEQ37088921-183F3EF0-B020-4F1A-BB7F-51DA5BA67155Q37269289-DB08887E-E73E-4077-9A28-ED9CBFBB775DQ38540375-C0395E5F-8457-4DCB-A55C-6AE5C62768A4Q38805786-0A7CE823-7FC1-4585-B957-674A6F7172DDQ39404128-EED05C87-AC74-4927-AEFC-497A8F7A2C2DQ40723827-73DDD383-EB2A-4F25-A33A-43D40DCE5EB5Q50201988-F2642E64-A5EB-4199-A56E-292F18C5BEAFQ50958719-DE96939B-220B-4782-BAFC-0E57EC673853Q53382084-FDC5765A-447D-43A9-BA4B-14D209E8E0A3
P2860
SALL4 immunoreactivity predicts prognosis in Western hepatocellular carcinoma patients but is a rare event: a study of 236 cases.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
SALL4 immunoreactivity predict ...... e event: a study of 236 cases.
@en
SALL4 immunoreactivity predict ...... e event: a study of 236 cases.
@nl
type
label
SALL4 immunoreactivity predict ...... e event: a study of 236 cases.
@en
SALL4 immunoreactivity predict ...... e event: a study of 236 cases.
@nl
prefLabel
SALL4 immunoreactivity predict ...... e event: a study of 236 cases.
@en
SALL4 immunoreactivity predict ...... e event: a study of 236 cases.
@nl
P2093
P2860
P1476
SALL4 immunoreactivity predict ...... e event: a study of 236 cases.
@en
P2093
Elizabeth M Brunt
Neeta Vachharajani
William C Chapman
P2860
P304
P356
10.1097/PAS.0000000000000218
P407
P577
2014-07-01T00:00:00Z